Kenox Pharmaceuticals Inc. Announces Clinical Manufacturing Readiness for Nasal and Inhaled Drug Products
PR Newswire —
PRINCETON, N.J., March 4, 2026 /PRNewswire/ -- Kenox Pharmaceuticals Inc. (Kenox), a fast‑growing contract development and manufacturing organization (CDMO) dedicated exclusively to Orally Inhaled and Nasal Drug Products (OINDPs) and Ophthalmic Drug Products, today announced that it is...